Q32 Bio Inc. Files Definitive Proxy Materials
Ticker: QTTB · Form: DEFA14A · Filed: Apr 30, 2026 · CIK: 0001661998
| Field | Detail |
|---|---|
| Company | Q32 Bio Inc. (QTTB) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, shareholder-meeting, regulatory
TL;DR
Q32 Bio Inc. filed proxy materials on 4/30/26. Shareholders likely voting soon.
AI Summary
Q32 Bio Inc. filed a DEFA14A on April 30, 2026, related to additional definitive proxy soliciting materials. The filing, with SEC Accession No. 0001193125-26-193953, originates from their Waltham, MA office. The company, CIK 0001661998, operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates that Q32 Bio Inc. is engaging in proxy solicitations, which are crucial for shareholder voting on important company matters.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain information that inherently increases risk.
Key Numbers
- 2026-04-30 — Filing Date (Date of the DEFA14A filing)
Key Players & Entities
- Q32 Bio Inc. (company) — Filer
- 0001193125-26-193953 (other) — SEC Accession Number
- 0001661998 (other) — CIK Number
- 2834 (other) — SIC Code
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used for additional definitive proxy soliciting materials and Rule 14(a)(12) material, meaning it contains information used to solicit proxies from shareholders.
What is Q32 Bio Inc.'s CIK number?
Q32 Bio Inc.'s CIK number is 0001661998.
Where is Q32 Bio Inc. located?
Q32 Bio Inc.'s mailing and business address is 830 WINTER STREET WALTHAM MA 02451.
What industry does Q32 Bio Inc. operate in?
Q32 Bio Inc. operates in the Pharmaceutical Preparations sector, with a SIC code of 2834.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001193125-26-193953.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2026 regarding Q32 Bio Inc. (QTTB).